Tackling COVID-19 – the COVIRNA project kicks-off
1 December 2020
The COVIRNA project, led by the Luxembourg Institute of Health (LIH), is one of the 23 research projects awarded within the framework of the Horizon 2020 call for Expression of Interest “Innovative and rapid health-related approaches to respond to COVID-19 and to deliver quick results for society for a higher level of preparedness of health systems”. The project aims to develop a novel diagnostic test to predict COVID-19 outcomes for patients and improve the cooperation between European research institutions to strengthen the response to the pandemic.
THE COVIRNA PROJECT IS BORN
On 19 May 2020, the European Commission launched the Second call for an Expression of Interest for innovative and rapid health-related approaches to respond to COVID-19 and to deliver quick results for society for a higher level of preparedness of health systems (SC1-PHECORONAVIRUS-2020-2) as part of the ERAvsCORONA Action Plan. An overall budget of €128.2 million is mobilised under this call, mainly originating from the Horizon 2020 (H2020) Framework Programme as part of the Commission’s EUR 1.4 billion pledge to the Coronavirus Global Response. Complementing a first call aimed at advancing the knowledge of SARS-CoV-2 in relation to potential clinical and public health measures, this second call focused on wide-scale, rapid (within 3-24 months) deployment of readily available health-based technological solutions to manage and contain this current and future outbreaks.
In this context, and building on the network developed within the EU-CardioRNA (“Catalyzing transcriptomics research in cardiovascular disease”) COST Action, a consortium of 15 academic and innovative SME partners polled their expertise and resources (notably by providing access to various European COVID-19 clinical cohorts) to build a multidisciplinary and multicentre study with the common aim to improve individualised surveillance, care and follow-up of COVID-19 patients in the context of the current pandemic.
Awarded under the topic SC1-PHE-CORONAVIRUS-2B (Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels), the COVIRNA project started in November 2020 and will last 24 months.
WHAT COVIRNA IS
The LIH, through the Cardiovascular Research Unit of the Department of Population Health (DoPH), led by Dr Yvan Devaux, will be the Coordinator of “COVIRNA” (A diagnostic test to improve surveillance and care of COVID-19 patients). COVIRNA is a patient-centred Innovation Action aiming to generate a diagnostic tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications, ultimately leading to their improved surveillance and care. In particular, the project will complete and deploy a prognostic system based on cardiovascular biomarkers of COVID-19 clinical outcomes, combined with a predictive model built on digital tools and artificial intelligence analytics.
The team will conduct a large retrospective study on multiple existing cohorts of COVID-19 patients throughout Europe and upscale the already validated and patented “FIMICS” panel of cardiac-enriched long noncoding RNA biomarkers into an in-vitro diagnostic test (COVIRNA), adapted to COVID-19 patients. The study will therefore rapidly deliver a minimally-invasive, simple yet robust and affordable prognostic assay that can be used in the context of the current COVID-19 pandemic, as well as in further major health crises.
“By tackling the cardiovascular complications of COVID-19, which are known to contribute significantly to mortality, the project is expected to have a major impact on patient outcomes”, explains Dr Yvan Devaux. “The COVIRNA test will be CE-marked and made ready to be commercialised, allowing the stratification of patients according to their risk of developing cardiac side-effects, thereby improving therapeutic approaches and informing novel drug design”, he concludes.
THE COVIRNA TEAM
With a total budget of EUR 4.44 million and EUR 3.88 million of EU contribution, the project boasts a complementary consortium of 15 partners from healthcare, academia and industry from 12 European countries. The partners are:
- Luxembourg Institute of Health (LU)
- Firalis SA (FR)
- University of Luxembourg (LU)
- Imperial College of Science and Technology Medicine (UK)
- University of Maastricht (NL)
- European Health Management Association (BE)
- Heinrich-Heine-University of Düsseldorf (DE)
- The University of Edinburgh (UK)
- International University of Sarajevo (BA)
- Policlinico San Donato SPA (IT)
- Pharmahungary 2000 Kft (HU)
- University of Leipzig (DE)
- Jožef Stefan Institute (SI)
- Fundació Privada Institut de Recerca de l`Hospital de la Santa Creu i Sant Pau (SP)
- University of Coimbra (PT)
The COVIRNA project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101016072. This page and the publications contained herein only reflects the author’s views. The European Union is not liable for any use that might be made of the information contained in this page and publications.
RSV immunisation for infants in Europe: are our health systems ready?
Proposed amendments to the reformed Pharmaceutical Legislation: patient safety and medication shortages
Discover the European Health Management Conference Tracks
What our Members say
I have been active in EHMA since the first years of the '90s and I have seen its evolution from a small association of members interested in sharing knowledge on health management practices to the current status of reference and advisory key player for EU, health systems and organisations, stakeholders associations, industry and universities. EHMA is now a unique knowledge hub, policy advisor, community of practice and network of best in class organisations involved in health policy and management. A place where health managers can build their competences, policy-makers and stakeholder associations envision how to implement and sustain change through health management, industry leaders understand how to engage more effectively with health organisations and systems. The right place to nurture and grow health management capabilities and capacity for every stakeholder of health systems.
Prof. Federico Lega, University of Milan, Italy
Health management has a crucial function in shaping public health and health system challenges. The Medical University of Varna, Bulgaria had success in collaborating with EHMA on EU-funded projects that has resourced us to create new health management competencies for the future workforce. In addition to all classical definitions, health management is a science dealing with individuals, groups, and society at large. It is an art contributing to the beauty of our lives and an interactive communication process at all levels of institutions and human energy. I have also had the pleasure to chair the South Eastern European Special Interest Group which gives members a space to discuss and tools to address how health systems are managed in our regions.
Prof. Todorka Kostadinova, Medical University of Varna, Bulgaria
I enjoy the high level of interaction and engagement in EHMA’s activities, in particular during the annual conference where the panel discussions are rich and well prepared. As a hospital manager and professor of health management, EHMA motivates and inspires me to be creative. You go back home feeling energised from seeing old friends and making new connections, as well as being convinced of serving as EHMA’s ambassador. It’s a strong feeling of interdisciplinary engagement, but it also feels like being part of family-like community.
Prof. Sandra C. Buttigieg, University of Malta, Malta
EHMA is a pre-eminent organisation for everyone working in planning, managing and delivering health services across Europe. As a long standing member of EHMA I have always been impressed by the vibrant community of managers, researchers and academics it has created and by the many opportunities for sharing knowledge and funding opportunities it has brought to its members. Its international scope is impressive and its impact is often felt in management and research across European and national health systems.
Prof. Axel Kaehne, Edge Hill University, UK
Health workforce has become more essential in operating, managing and maintaining health systems lately, particularly in crisis and emergency situations. European healthcare professions and the workforce need to be high on the agenda of managers and decision makers. The Health Services Management Training Centre, Semmelweis University in Hungary is a longstanding EHMA member, because it connects us with collaborators and experts, with whom we can have complex debates, from whom we can learn and at the end find solutions in various challenging fields of healthcare management.
Dr Eszter Kovács, Health Services Management Training Centre, Semmelweis University, Hungary
As a hospital administrator and health management professor, I see on a daily basis that the healthcare challenges require talented and skilled managers to transform it. the EHMA membership has been beneficial to bring healthcare management research and education to the demanding healthcare services world, promoting healthcare management competencies and knowledge creation.
Dr Alexandre Lourenco, APAH - Association of Portuguese Hospital Managers, Portugal
Many healthcare systems in Europe and beyond are facing similar challenges which require innovative and creative solutions. EHMA’s annual conference, webinars, Programme Directors’ group and other activities and resources provide incredible opportunities for networking, connecting and sharing experiences. A distinct feature of EHMA is the diversity of members with representation from many countries, sectors and different communities of practice – academic, policy-makers, practitioners, managers, leaders and students. The annual conference is a highlight in the calendar year, offering a friendly, fun and learningful environment for emerging and established members to engage, collaborate and meet up with old and new friends. I am proud to be a member of the EHMA Board.
Prof. Ann Mahon, University of Manchester, UK
Society evolution, pandemics and ageing modify health needs. So, health policies and services are to change dramatically. EHMA, through webinars, workshops and annual conference provides an excellent insight to a professional changing world, favouring closeness to management innovation and the protagonists of these changes. As a primary care services’ manager, participating in EHMA activities is really worth it and allows to involve oneself in the innovation processes.
Dr Antoni Peris Grao, Consorci Castelldefels Agents de Salut (CASAP), Spain